Vectus Biosystems (ASX:VBS)
ASX announcement history & article coverage
Transparent by design.
Announcments by Vectus Biosystems (ASX:VBS) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Full Year Statutory Accounts
Preliminary Final Report
Vectus Biosystems posts AUD 1.56 million profit for FY2026, reversing prior year loss
Cleansing Notice
Application for quotation of securities - VBS
Quarterly Activities & Appendix 4C Cash Flow Reports
Vectus Biosystems appoints new CEO, raises $0.79M, sells renal compound, and engages US regulatory agent
VBS Engages CHRS as Regulatory Agent for FDA Submissions
Vectus appoints Cardinal Health as US FDA regulatory agent for VB0004
Cleansing Notice
Application for quotation of securities - VBS
CEO Investor Webinar